Glanbia PLC (GL9) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Glanbia PLC (GL9) has a cash flow conversion efficiency ratio of 0.020x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€40.70 Million ≈ $47.58 Million USD) by net assets (€2.01 Billion ≈ $2.35 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Glanbia PLC's balance sheet to measure how much of total assets are equity-financed.
Glanbia PLC - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Glanbia PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Glanbia PLC earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Glanbia PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Glanbia PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cogent Biosciences Inc
NASDAQ:COGT
|
-0.124x |
|
Compagnie du Cambodge
PA:CBDG
|
0.004x |
|
Churchill Downs Incorporated
NASDAQ:CHDN
|
0.091x |
|
Suzhou Everbright Photonics Co. Ltd. A
SHG:688048
|
-0.001x |
|
Inner Mongolia Junzheng Energy & Chemical Group Co Ltd
SHG:601216
|
0.043x |
|
Capital Securities Corp. Ltd.
SHG:601136
|
0.021x |
|
Ameris Bancorp
NYSE:ABCB
|
0.063x |
|
QMMM Holdings Limited Ordinary Shares
NASDAQ:QMMM
|
-0.103x |
Annual Cash Flow Conversion Efficiency for Glanbia PLC (1991–2025)
The table below shows the annual cash flow conversion efficiency of Glanbia PLC from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Glanbia PLC stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €1.93 Billion ≈ $2.25 Billion |
€368.50 Million ≈ $430.82 Million |
0.191x | -10.57% |
| 2024-12-31 | €2.07 Billion ≈ $2.42 Billion |
€443.20 Million ≈ $518.15 Million |
0.214x | +6.59% |
| 2023-12-31 | €2.13 Billion ≈ $2.49 Billion |
€427.80 Million ≈ $500.14 Million |
0.201x | +25.65% |
| 2022-12-31 | €1.87 Billion ≈ $2.18 Billion |
€298.30 Million ≈ $348.74 Million |
0.160x | +10.65% |
| 2021-12-31 | €1.74 Billion ≈ $2.03 Billion |
€251.10 Million ≈ $293.56 Million |
0.144x | -16.16% |
| 2020-12-31 | €1.61 Billion ≈ $1.88 Billion |
€277.40 Million ≈ $324.31 Million |
0.172x | +37.84% |
| 2019-12-31 | €1.70 Billion ≈ $1.99 Billion |
€212.50 Million ≈ $248.43 Million |
0.125x | -27.88% |
| 2018-12-31 | €1.59 Billion ≈ $1.86 Billion |
€275.10 Million ≈ $321.62 Million |
0.173x | +162.56% |
| 2017-12-31 | €1.38 Billion ≈ $1.62 Billion |
€91.10 Million ≈ $106.51 Million |
0.066x | -74.95% |
| 2016-12-31 | €1.23 Billion ≈ $1.43 Billion |
€322.91 Million ≈ $377.51 Million |
0.263x | +1.10% |
| 2015-12-31 | €1.06 Billion ≈ $1.24 Billion |
€276.71 Million ≈ $323.51 Million |
0.260x | +20.63% |
| 2014-12-31 | €804.78 Million ≈ $940.87 Million |
€173.65 Million ≈ $203.01 Million |
0.216x | +28.88% |
| 2013-12-31 | €643.52 Million ≈ $752.34 Million |
€107.74 Million ≈ $125.96 Million |
0.167x | +24.83% |
| 2012-12-31 | €544.66 Million ≈ $636.76 Million |
€73.05 Million ≈ $85.40 Million |
0.134x | -31.85% |
| 2011-12-31 | €522.95 Million ≈ $611.38 Million |
€102.92 Million ≈ $120.32 Million |
0.197x | +19.93% |
| 2010-12-31 | €424.40 Million ≈ $496.17 Million |
€69.65 Million ≈ $81.42 Million |
0.164x | -28.96% |
| 2009-12-31 | €297.39 Million ≈ $347.68 Million |
€68.69 Million ≈ $80.31 Million |
0.231x | -41.56% |
| 2008-12-31 | €227.92 Million ≈ $266.46 Million |
€90.08 Million ≈ $105.32 Million |
0.395x | +49.31% |
| 2007-12-31 | €234.57 Million ≈ $274.24 Million |
€62.10 Million ≈ $72.60 Million |
0.265x | +52.61% |
| 2006-12-31 | €200.52 Million ≈ $234.43 Million |
€34.78 Million ≈ $40.66 Million |
0.173x | -84.32% |
| 2005-12-31 | €123.72 Million ≈ $144.64 Million |
€136.88 Million ≈ $160.03 Million |
1.106x | +279.99% |
| 2004-12-31 | €230.29 Million ≈ $269.24 Million |
€67.05 Million ≈ $78.39 Million |
0.291x | +105.13% |
| 2003-12-31 | €298.04 Million ≈ $348.44 Million |
€42.30 Million ≈ $49.46 Million |
0.142x | -40.14% |
| 2002-12-31 | €320.44 Million ≈ $374.62 Million |
€75.99 Million ≈ $88.84 Million |
0.237x | -31.77% |
| 2001-12-31 | €322.76 Million ≈ $377.34 Million |
€112.18 Million ≈ $131.15 Million |
0.348x | +27.05% |
| 2000-12-31 | €289.72 Million ≈ $338.72 Million |
€79.26 Million ≈ $92.66 Million |
0.274x | +115.64% |
| 1999-12-31 | €272.70 Million ≈ $318.81 Million |
€34.59 Million ≈ $40.45 Million |
0.127x | -60.16% |
| 1998-12-31 | €216.29 Million ≈ $252.87 Million |
€68.88 Million ≈ $80.53 Million |
0.318x | +22.10% |
| 1997-12-31 | €188.46 Million ≈ $220.33 Million |
€49.15 Million ≈ $57.46 Million |
0.261x | +68.36% |
| 1996-12-31 | €294.46 Million ≈ $344.25 Million |
€45.61 Million ≈ $53.33 Million |
0.155x | -51.24% |
| 1995-12-31 | €194.37 Million ≈ $227.24 Million |
€61.74 Million ≈ $72.19 Million |
0.318x | +61.55% |
| 1994-12-31 | €170.04 Million ≈ $198.80 Million |
€33.44 Million ≈ $39.09 Million |
0.197x | -56.69% |
| 1993-12-31 | €120.61 Million ≈ $141.00 Million |
€54.76 Million ≈ $64.01 Million |
0.454x | +304.77% |
| 1992-12-31 | €121.16 Million ≈ $141.65 Million |
€13.59 Million ≈ $15.89 Million |
0.112x | -12.06% |
| 1991-12-31 | €138.35 Million ≈ $161.74 Million |
€17.64 Million ≈ $20.63 Million |
0.128x | -- |
About Glanbia PLC
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes produ… Read more